Combining tissue profiling with whole transcriptome spatial analysis and high-plex protein co-detection enables a deeper, more holistic understanding of tissue organization PLEASANTON, Calif., May 24, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of a new Visium CytAssist Gene and Protein Expression … Read more
ALAMEDA, Calif., May 24, 2023 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at William Blair’s 43rd Annual Growth Stock Conference on Wednesday, June 7, 2023. Event: William Blair’s 43rd Annual Growth Stock Conference Date: Wednesday, June 7, 2023 Time: 9:20am CT/ 7:20am PT A webcast … Read more
LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ — BIOLASE, Inc. (NASDAQ: BIOL) (“BIOLASE” or the “Company”), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the “Units”), with each Unit consisting of one share of BIOLASE’s Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with … Read more
Dr. Winterbottom will serve the role of SVP, Product Development & Manufacturing Operations RIVERDALE, Md., May 24, 2023 /PRNewswire/ — Medcura, Inc. has added Dr. Neil Winterbottom to its leadership team to accelerate the spine indication approval and commercialization of LifeGel™, Medcura’s flagship surgical hemostat. Medcura, Inc. is delighted to welcome biochemist Dr. Neil Winterbottom … Read more
CAMBRIDGE, Mass., May 24, 2023 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate in a fireside chat during the TD Cowen 4th Annual Oncology Innovation … Read more
– Preclinical and early research gene therapy programs discontinued –– Expected reductions of approximately 15% in residual 2023 OPEX – SOUTH PLAINFIELD, N.J., May 23, 2023 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the discontinuation of preclinical and early research programs in gene therapy as part of a strategic portfolio prioritization. PTC will continue … Read more
PLYMOUTH MEETING, Pa., May 23, 2023 /PRNewswire/ — INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that the European Commission (EC) has granted orphan drug designation for INO-3107, the company’s product candidate for the treatment of Recurrent Respiratory … Read more
– Conference call and webcast to be held at 5:00 pm EDT – SOUTH PLAINFIELD, N.J., May 23, 2023 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today reported topline results from the MOVE-FA trial of vatiquinone in patients with Friedreich ataxia. The study did not meet its primary endpoint of statistically significant change in mFARS score … Read more
CHICAGO, May 23, 2023 /PRNewswire/ — GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company (the “Company”), today announced that its Board of Directors (the “Board”) established a special committee of the Board (the “Special Committee”) to consider a proposal (the “Proposal”) from its two largest stockholders to acquire all … Read more
Partnership to Provide Free Access to Tele-Mental Health Platform 24/7/365 and Diverse Team of Providers for Students at 44 Institutions of Higher Education TRENTON, N.J., May 23, 2023 /PRNewswire/ — As part of the Murphy Administration’s ongoing efforts to address the growing youth mental health crisis, Governor Phil Murphy and Secretary of Higher Education Dr. Brian … Read more